(Reuters) - Quest Diagnostics Inc, the No. 1 clinical laboratory-testing company, lowered its revenue forecast for the year but kept profit estimates unchanged as it continues to cut costs to improve margins. The company expects revenue to grow between 1 percent and 2 percent in 2012. It had previously forecast a growth of between 2 percent and 2.5 percent. Quest maintained its previous earnings outlook of $4.45 to $4.60 a share. Net income from continuing operations was $178 million, or $1.11 per share, in the second quarter, compared with $164 million, or $1.02 per share, a year earlier. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment